Business Context and Reporting Period
This Form 8-K reports on the 2021 Annual Meeting of Stockholders held by MEDICINOVA INC on June 16, 2021. The company is incorporated in Delaware and trades on The Nasdaq Stock Market LLC under the symbol MNOV.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting results.
Material Changes and Voting Results
At the record date of April 19, 2021, the company had 48,768,541 shares of common stock issued and outstanding. A quorum was established with 37,078,138 shares present at the meeting. Two matters were submitted to a vote:
- Election of Directors: Two Class II Director nominees were elected to serve until the 2024 Annual Meeting:
- Yuichi Iwaki: 25,380,059 votes For; 3,148,892 Against; 5,982,489 Abstain.
- Kazuko Matsuda: 31,086,138 votes For; 2,944,818 Against; 480,484 Abstain.
- Ratification of Auditors: The selection of BDO USA, LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2021, was approved.
- Votes: 34,132,991 For; 2,399,346 Against; 534,901 Abstain.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Investor Verification Checklist
- Verify the definitive proxy statement filed on April 27, 2021, for detailed background on the director nominees and auditor selection.
- Confirm the total number of shares outstanding (48,768,541) against subsequent filings to check for dilution or buybacks.
- Review the "Against" vote counts for directors to assess shareholder sentiment regarding the board composition.
- Check subsequent filings for the appointment of BDO USA, LLP as the official auditor for the 2021 fiscal year.